
Sign up to save your podcasts
Or


It’s rare, it’s aggressive—and often undetected until it’s advanced. In this deep dive, we uncover the truth about ocular melanoma, a form of eye cancer that starts in pigment-producing cells and affects just 5 to 6 people per million each year.
🎯 What you’ll learn:
From diagnosis shock to survivorship challenges, this episode offers clarity, compassion, and concrete action steps—so you or someone you care about never faces ocular melanoma alone.
Esophageal cancer is one of the deadliest cancers—with a 5-year survival rate of just 20%. In this eye-opening deep dive, we unpack the realities of this complex disease and how science is pushing back with innovative diagnostics, treatments, and prevention strategies.
🔍 What you’ll learn:
Whether you or someone you love is facing esophageal cancer—or you just want to understand the risks—this episode equips you with clarity, context, and cutting-edge knowledge.
In this vital deep dive, we unpack one of the most common—and most underrecognized—cancers affecting women: endometrial cancer. From understanding key symptoms like abnormal bleeding to breaking down powerful personal stories and the latest research innovations, this episode empowers you with knowledge that could save lives.
🔍 What you'll learn:
Whether you're looking out for yourself or a loved one, this conversation offers clarity, credibility, and actionable insight. Sponsored by StoneFly, trusted leaders in enterprise backup and disaster recovery solutions.
This powerful episode delivers a thorough look at cervical cancer—from its biological roots to the global push for elimination. You’ll learn:
Whether you're a healthcare professional, policymaker, or advocate, this episode equips you with the knowledge and urgency to make a difference in the fight against cervical cancer.
Welcome to vpod.ai’s The Deep Dive, proudly sponsored by StoneFly. In this episode, we explore the complex, often misunderstood world of neuroendocrine tumors (NETs)—from silent symptoms to cutting-edge treatments revolutionizing outcomes.
You'll learn:
This is the frontline of rare cancer research—where collaboration, innovation, and precision medicine are making a real difference.
This in-depth episode offers a comprehensive overview of breast cancer—from understanding risk factors to navigating diagnosis and cutting-edge treatment. You’ll learn:
Whether you’re newly diagnosed, supporting someone, or just seeking to stay informed, this episode delivers clarity, compassion, and actionable knowledge for every step of the journey.
This episode takes a critical deep dive into bone cancer, exploring the vital differences between rare primary bone cancers—like osteosarcoma, Ewing sarcoma, and chondrosarcoma—and the far more common secondary (metastatic) bone cancers that spread from other organs.
Key highlights include:
If you're facing or supporting a bone cancer diagnosis, this episode offers essential insights into navigating treatment with clarity, strategy, and the best chances for preservation and recovery.
This episode delivers a comprehensive deep dive into Basal Cell Carcinoma (BCC)—the most common yet often overlooked cancer in the world. You’ll learn:
If you've ever wondered about that spot on your skin—or how to protect yourself—this episode offers clear, expert-driven insights for prevention, vigilance, and effective care
Welcome to vpod.ai your shortcut to staying truly well-informed. In this medically rich episode, we take an in-depth look at Acute Lymphoblastic Leukemia (ALL), a fast-moving blood and bone marrow cancer.
You’ll discover:
Whether you’re navigating a diagnosis or just curious about cutting-edge hematology, this episode breaks down the science and strategy behind today’s most advanced ALL treatments.
this episode delivers an in-depth look at calciphylaxis—a rare, life-threatening condition that primarily affects patients with kidney failure on dialysis. You’ll learn:
An essential listen for clinicians and caregivers navigating the complexities of this painful and poorly understood condition.
From the publisher's feed